Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2007; 13(32): 4306-4309
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4306
Published online Aug 28, 2007. doi: 10.3748/wjg.v13.i32.4306
Table 1 Overview of the important published results from trials in regional intra-arterial chemotherapy in the palliative treatment of pancreas cancer
| Author | n | Cytostatic agents | Responserate (%) | Survival time (mo) |
| Mambrini[35] | 211 | 5-FU, Leucovorin | 7.2 | 9.2 |
| Epirubicin, Carboplatin | ||||
| Theodors[29] | 19 | 5-FU, MMC, Doxorubicin | 42.0 | 5.2 |
| Maurer[37] | 12 | MXT, 5-FU | 8.0 | 6.0 |
| Homma[38] | 31 | 5-FU, CDDP | 73.9 | 18.0 |
| Cantone[39] | 96 | 5-FU/Folic Acid, Carboplatin | 15.0 | 9.9 |
| Gausauge[40] | 32 | MXT | 19.0 | 7.5 |
| Lorenz[41] | 17 | GEM, MMC | 24.0 | 9.1 |
| Author's data[43] | 20 | GEM, 5-FU, CDDP (Tegafur/Uracil) | 25.0 | 12.0 |
| Angiotensin-II |
- Citation: Ishikawa T. Is it relevant that intra-arterial chemotherapy may be effective for advanced pancreatic cancer? World J Gastroenterol 2007; 13(32): 4306-4309
- URL: https://www.wjgnet.com/1007-9327/full/v13/i32/4306.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i32.4306